News about Drug Discovery & Development

Alembic Pharma Secures USFDA Tentative Approval for Bosutinib Tablets

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Bosutinib Tablets, 100 mg and 500 mg.

Drug Discovery & Development | 02/07/2024 | By Aishwarya |  1003

Avantor Launches Two New J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease

Avantor, Inc. announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease.

Drug Discovery & Development | 01/07/2024 | By Manvi |  506

Alembic Pharmaceuticals Secures FDA Final Approval for Doxycycline Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Capsules, 40 mg.

Drug Discovery & Development | 29/06/2024 | By Aishwarya |  431

Lupin Gets Tentative Approval from FDA for Olopatadine Hydrochloride Ophthalmic Solution

Lupin has received a tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 percent (OTC).

Drug Discovery & Development | 28/06/2024 | By Aishwarya |  744

WACKER & CordenPharma Enter Pandemic Readiness State for Germany

WACKER and CordenPharma have officially entered the pandemic readiness state as of June 1, 2024.

Drug Discovery & Development | 25/06/2024 | By Aishwarya |  377

Ethypharm Signs Deal with MTPC to Acquire Argatroban Monohydrate

Ethypharm has signed an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to acquire the selective antithrombin agent, Argatroban monohydrate (Argatra, Arganova, Novastan, Exembol), in Europe.

Drug Discovery & Development | 18/06/2024 | By Aishwarya |  990

Sun Pharma, Moebius Medical Anti-Osteoarthritis Injection Offers Sustained Pain Relief in Clinical Trials

Sun Pharmaceutical Industries and Moebius Medical have presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post injection of MM-II.

Drug Discovery & Development | 15/06/2024 | By Aishwarya |  633

Glenmark Gets ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules

Glenmark has secured final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium Delayed-Release Capsules.

Drug Discovery & Development | 15/06/2024 | By Aishwarya |  388

Akums Launches Rabeprazole + Levosulpiride SR Capsules

Akums Akums Drugs & Pharmaceuticals Ltd. announced that it has launched Rabeprazole + Levosulpiride SR Capsules. Approved by the Drug Controller General of India (DCGI), the company claims this new formulation aims to enhance relief for patients suffering from gastrointestinal tract (GIT) disorders.

Drug Discovery & Development | 14/06/2024 | By Manvi |  895

AbbVie and FutureGen to Develop Next-Gen Therapy for Inflammatory Bowel Disease

AbbVie has signed a license agreement with FutureGen Biopharmaceutical to develop FG-M701, a next-generation TL1A antibody for the treatment of IBD currently in preclinical development.

Drug Discovery & Development | 14/06/2024 | By Aishwarya |  523